Biotechnology Business
Cell Therapeutics, Inc. (CTI) Decreases Net Loss by 42% in 2009
Published in Medical Letter on the CDC and FDA, February 28th, 2010
aggressive non-Hodgkin's lymphoma filed with the U.S. Food and Drug
Administration (the "FDA") and accepted for review in 2009. The FDA
established Prescription Drug User Fee Act (PDUFA) date of April 23,
2010. -- Initiated a Marketing Authorization Application ("MAA") for pixantrone
in Europe in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Elsevier
Predicting effectiveness of flu vaccination campaigns - University of Maryland Medical Center
Study finds new stent improves ability to keep vessels open for dialysis patients - Allegheny General Hospital
Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment - Clinical Trial Research
Research from E.T. Weiss et al broadens understanding of clinical trial research - Female Sexual Dysfunction
Data on female sexual dysfunction discussed by researchers at University of Virginia - Life Sciences
Drexel University details research in life sciences - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
